Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kyle J Hill

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Frontiers in Microbiology|July 18, 2019
GS-CA Compounds: First-In-Class HIV-1 Capsid Inhibitors Covering Multiple GroundsKamal Singh, Fabio Gallazzi, Kyle J Hill, et al.
AIDS (London, England)|November 27, 2018
Strain-specific effect on biphasic DNA binding by HIV-1 integraseKyle J Hill, Leonard C Rogers, Duncan T Njenda, et al.
Pathogens (Basel, Switzerland)|May 3, 2020
Feasibility of Known RNA Polymerase Inhibitors as Anti-SARS-CoV-2 DrugsUjjwal Neogi, Kyle J Hill, Anoop T Ambikan, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Frontiers in Microbiology|July 18, 2019
GS-CA Compounds: First-In-Class HIV-1 Capsid Inhibitors Covering Multiple GroundsKamal Singh, Fabio Gallazzi, Kyle J Hill, et al.
AIDS (London, England)|November 27, 2018
Strain-specific effect on biphasic DNA binding by HIV-1 integraseKyle J Hill, Leonard C Rogers, Duncan T Njenda, et al.
Pathogens (Basel, Switzerland)|May 3, 2020
Feasibility of Known RNA Polymerase Inhibitors as Anti-SARS-CoV-2 DrugsUjjwal Neogi, Kyle J Hill, Anoop T Ambikan, et al.
Pageof 1